Preventing another stroke in small vessel disease with cilostazol
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether the drug cilostazol can help prevent another stroke and slow down damage to the brain's small blood vessels. It may be a good option if you have recently had a small-vessel stroke and have white matter changes on your MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a stroke caused by a blocked small blood vessel in the brain within the last 6 months.
- An MRI of your brain shows white matter changes (grade 2 or higher on the Fazekas scale).
- You can walk and take care of yourself (modified Rankin score of 2 or less).
- You do not have severe memory or thinking problems (Clinical Dementia Rating below 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the drug cilostazol can help prevent another stroke or mini-stroke (TIA) in people who have already had one. It compares adding cilostazol to the standard blood-thinning medicines you and your doctor would normally use.
This study tests whether the drug cilostazol, when added to your usual aspirin or clopidogrel, can help prevent another stroke. It is being done in Africa and may be a good option if you've recently had a stroke or mini-stroke and want to lower your risk of another one.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
This trial tests if a medicine called cilostazol can reduce the risk of a delayed shortage of blood in the brain after having a bleeding aneurysm treated. It aims to improve recovery by preventing a common complication called delayed cerebral ischemia.
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
Hear when a new Cerebral Small Vessel Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.